换一批Pretreatment neutrophil-to-lymphocyte ratio in metastatic castration-resistant prostate cancer patients treated with ketoconazole: association with outcome and predictive nomogram.
第一作者：
Daniel,Keizman
第一单位：
Genitourinary Oncology Service, Institute of Oncology, Meir Medical Center, Sackler School of Medicine, Tel Aviv University, Kfar-Saba, Israel. danielkeizman@gmail.com
作者：
医学主题词
老年人(Aged);老年人, 80以上(Aged, 80 and over);雄激素拮抗药(Androgen Antagonists);无病生存(Disease-Free Survival);促性腺素释放激素(Gonadotropin-Releasing Hormone);人类(Humans);酮康唑(Ketoconazole);Logistic模型(Logistic Models);淋巴细胞计数(Lymphocyte Count);男(雄)性(Male);中年人(Middle Aged);多元分析(Multivariate Analysis);中性白细胞(Neutrophils);列线图(Nomograms);比例危险度模型(Proportional Hazards Models);前列腺特异抗原(Prostate-Specific Antigen);前列腺肿瘤(Prostatic Neoplasms);回顾性研究(Retrospective Studies);危险因素(Risk Factors);类固醇17-α-羟化酶(Steroid 17-alpha-Hydroxylase);治疗结果(Treatment Outcome)
DOI
10.1634/theoncologist.2012-0125
PMID
22971522
发布时间
2022-04-08
- 浏览18
The oncologist
1508-14页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
